does masshealth cover glp 1 for weight loss Governor Healey's Fiscal Year 2027 budget plan proposes cuts to coverage, including completely removing coverage GLP-1 medications MassHealth and the Group Insurance

The FDA has approved Semaglutide GLP-1 for long-term use in managing chronic weight, which means that it can be taken for an extended period when necessary

That number comes from randomized clinical research

However, to ensure safety, it is important to purchase products that have been tested by an independent lab whenever possible

Results can vary from person to person, but many people start to see initial improvements within one to two weeks of their first injection, with more significant changes appearing over the following months

These changes may make it more difficult to lose weight using the same methods that worked in the past